Skip to main content

Table 3 Risk of recurrence/death per 1 U/ml CA-125 3 and 6 months after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Risk of Time after treatment HR 95%CI P
Recurrence 3 months 1.083 1.05–1.12 < 0.0001
6 months 1.018 1.01–1.03 < 0.0001
Death 3 months 1.08 1.03–1.13 0.0007
6 months 1.02 1.01–1.03 0.0001